Karuna Therapeutics, Inc.
KRTXDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771917
Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Karuna Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
KRTX is no longer listed, so this page shows Q4 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 328
- +73 vs. Q3 2023
- Shares held
- 37.9M
- −225.4K (−0.6%) vs. Q3 2023
- Total value
- $12.0B
- +$5.55B (+85.9%) vs. Q3 2023
- New holders
- 109
- 105 more added
- Sold out
- 36
- 87 more reduced
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 2 | $269.8K |
| Q4 2023 | 328 | $12.0B |
| Q3 2023 | 257 | $6.46B |
| Q2 2023 | 289 | $8.16B |
| Q1 2023 | 247 | $7.02B |
| Q4 2022 | 248 | $6.81B |
| Q3 2022 | 256 | $7.65B |
| Q2 2022 | 195 | $3.77B |
| Q1 2022 | 178 | $3.73B |
| Q4 2021 | 171 | $3.83B |
| Q3 2021 | 159 | $3.13B |
| Q2 2021 | 160 | $2.93B |
| Q1 2021 | 157 | $3.02B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Karuna Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 225,060 | $71.2M | 0.02% | +6,721+3.1% | Added |
| Nan Fung Group Holdings Ltd | 225,688 | $71.4M | 44.49% | 00.0% | Unchanged |
| Fiera Capital Corp | 237,656 | $75.2M | 0.23% | +199+0.1% | Added |
| Boxer Capital, LLC | 250,000 | $79.1M | 3.94% | 00.0% | Unchanged |
| First Light Asset Management, LLC | 287,037 | $90.9M | 7.31% | −16,100−5.3% | Reduced |
| Balyasny Asset Management LLC | 315,892 | $100.0M | 0.28% | +208,093+193.0% | Added |
| Invesco Ltd. | 319,136 | $101.0M | 0.02% | −45,998−12.6% | Reduced |
| Norges Bank | 328,067 | $103.8M | 0.02% | −2,002−0.6% | Reduced |
| Brown Advisory Inc | 333,144 | $105.4M | 0.15% | +11,059+3.4% | Added |
| Woodline Partners LP | 357,473 | $113.1M | 1.23% | +334,751+1,473.2% | Added |
| Alliancebernstein L.P. | 377,155 | $119.4M | 0.05% | +13,787+3.8% | Added |
| UBS Group AG | 422,178 | $133.6M | 0.05% | +419,217+14,158.0% | Added |
| Rock Springs Capital Management LP | 515,024 | $163.0M | 4.02% | +9,591+1.9% | Added |
| Farallon Capital Management, L.L.C. | 522,000 | $165.2M | 1.03% | +519,800+23,627.3% | Added |
| Geode Capital Management, LLC | 569,722 | $180.4M | 0.02% | +24,649+4.5% | Added |
| HBK Investments L P | 635,960 | $201.3M | 4.81% | +635,960 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $252.3M | 63.99% | 00.0% | Unchanged |
| State Street Corp | 974,643 | $308.5M | 0.02% | +45,673+4.9% | Added |
| General Atlantic LLC | 986,710 | $312.3M | 4.48% | 00.0% | Unchanged |
| Pentwater Capital Management LP | 1,066,200 | $337.5M | 6.34% | +1,037,700+3,641.1% | Added |
| Wellington Management Group LLP | 1,134,046 | $358.9M | 0.07% | −151,462−11.8% | Reduced |
| Sofinnova Investments, Inc. | 1,381,149 | $437.1M | 24.49% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,961,587 | $620.9M | 0.08% | −773,251−28.3% | Reduced |
| BlackRock Inc. | 2,015,374 | $637.9M | 0.02% | +52,457+2.7% | Added |
| T. Rowe Price Investment Management, Inc. | 2,709,629 | $857.6M | 0.56% | −32,828−1.2% | Reduced |
| FMR LLC | 2,865,994 | $907.1M | 0.07% | −2,784,173−49.3% | Reduced |
| Vanguard Group Inc | 3,224,786 | $1.02B | 0.02% | +21,201+0.7% | Added |
| Capital International Investors | 4,227,102 | $1.34B | 0.30% | +236,491+5.9% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 0 | $0 | 0.00% | −1,131,263−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −151,450−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −139,618−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −110,556−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −86,670−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −51,311−100.0% | Sold out |
| Twin Tree Management, LP | 0 | $0 | 0.00% | −41,282−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −35,415−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −34,000−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −24,129−100.0% | Sold out |
| Commerce Bank | 0 | $0 | 0.00% | −18,336−100.0% | Sold out |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −16,445−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −9,071−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −7,900−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −6,440−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −4,084−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −3,880−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −2,556−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −2,275−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −1,875−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,555−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −1,481−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −490−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −128−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |